These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7897251)

  • 1. Interferon-alpha 2 produced by normal human leukocytes is predominantly interferon-alpha 2b.
    Dipaola M; Smith T; Ferencz-Biro K; Liao MJ; Testa D
    J Interferon Res; 1994 Dec; 14(6):325-32. PubMed ID: 7897251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of nine interferon-alpha subtypes produced by Sendai virus-induced human peripheral blood leucocytes.
    Nyman TA; Tölö H; Parkkinen J; Kalkkinen N
    Biochem J; 1998 Jan; 329 ( Pt 2)(Pt 2):295-302. PubMed ID: 9425112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a highly purified multicomponent leukocyte IFN-alpha product.
    Tölö H; Kauppinen HL; Alm G; Perers A; Lindeberg E; Wahlstedt-Fröberg V; Parkkinen J
    J Interferon Cytokine Res; 2001 Nov; 21(11):913-20. PubMed ID: 11747623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha neutralizing antibodies in HIV and chronic HCV patients treated with natural-source human leukocyte-derived interferon-alpha n3.
    Zhao XX; Hua J; Smith T; Ferencz-Biro K; Liao MJ; Rashidbaigi A
    Hum Antibodies; 1997; 8(3):129-36. PubMed ID: 9322083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased efficacy of human natural interferon alpha (IFN-alpha n3) versus human recombinant IFN-alpha 2 for inhibition of HIV-1 replication in primary human monocytes.
    Fan SX; Skillman DR; Liao MJ; Testa D; Meltzer MS
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1115-22. PubMed ID: 8312053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha 2 variants in the human genome.
    Lee N; Ni D; Brissette R; Chou M; Hussain M; Gill DS; Liao MJ; Testa D
    J Interferon Cytokine Res; 1995 Apr; 15(4):341-9. PubMed ID: 7627809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of natural human interferon omega 1. Two alternative cleavage sites for the signal peptidase.
    Adolf GR; Maurer-Fogy I; Kalsner I; Cantell K
    J Biol Chem; 1990 Jun; 265(16):9290-5. PubMed ID: 1693148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of various factors on interferon-alpha production in cultures of human leukocytes.
    Katschinski DM; Neustock P; Klüter H; Kirchner H
    J Interferon Res; 1994 Jun; 14(3):105-10. PubMed ID: 7930756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of interferons-alpha and -beta, tumor necrosis factor-alpha and transcription factors, IRF-1 and IRF-2, in leukocytes induced during interferon production.
    Lopez-Ocejo O; Herrera A; Herrera L; De la Fuente J
    Biol Res; 1995; 28(4):283-90. PubMed ID: 9251759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IFN-alpha-inducing capacity of Sendai Virus in human leukocytes is independent from the hemagglutinating and hemolytic activities and from the viral proteins of the Sendai Virus preparations.
    Mattana P; Scapol L; Silvestri S; Viscomi GC
    J Biol Regul Homeost Agents; 1999; 13(4):201-6. PubMed ID: 10703943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and bioassay of post-translationally modified interferon α-2b expressed in Escherichia coli.
    Ahsan F; Arif A; Mahmood N; Gardner QT; Rashid N; Akhtar M
    J Biotechnol; 2014 Aug; 184():11-6. PubMed ID: 24818536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased antiviral activity of microscale-purified HuIFN alpha 8 (human interferon alpha 8) over HuIFN alpha 2b in Hep-2 cells challenged with Mengo virus.
    García JC; Ariza AM; Lasa AM; González LJ; Perez VB
    Biotechnol Appl Biochem; 2007 Nov; 48(Pt 3):159-65. PubMed ID: 17523917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon immunogenicity: preclinical evaluation of interferon-alpha 2a.
    Palleroni AV; Aglione A; Labow M; Brunda MJ; Pestka S; Sinigaglia F; Garotta G; Alsenz J; Braun A
    J Interferon Cytokine Res; 1997 Jul; 17 Suppl 1():S23-7. PubMed ID: 9241612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of interleukin-10 on human leukocyte interferon-alpha production by Sendai virus.
    Zhao XX; Liao MJ; Rashidbaigi A
    Cytokines Cell Mol Ther; 1998 Mar; 4(1):11-6. PubMed ID: 9557212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon alpha 2b but not interferon alpha 2a detected in human genomic DNA.
    Kaluz S; Gibadulinová A; Kontsek P
    Acta Virol; 1993 Feb; 37(1):97-100. PubMed ID: 8105656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive and virus-induced interferon production by peripheral blood leukocytes.
    Greenway AL; Hertzog PJ; Devenish RJ; Linnane AW
    Exp Hematol; 1995 Mar; 23(3):229-35. PubMed ID: 7875240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive production of interferon-alpha 2 by a human B-lymphoblastoid cell line.
    Adolf GR; Pieler C; Maurer-Fogy I
    J Interferon Res; 1992 Aug; 12(4):275-80. PubMed ID: 1431307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three separate epitopes on human IFN-alpha variants defined by monoclonal antibodies and their role in the binding to receptors.
    Kandefer-Szerszeń M; Lundgren E
    Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):241-6. PubMed ID: 1284462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming with interferon-alpha 1 or interferon-alpha 2 enhances the production of both subtypes simultaneously.
    Fuchsberger N; Karayianni-Vasconcelos G; Kauppinen HL; Hajnicka V; Kontsek P
    J Interferon Cytokine Res; 1995 Jul; 15(7):637-9. PubMed ID: 7553235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon and tumor necrosis factor production by peripheral blood leukocytes of patients with infectious mononucleosis.
    Kamińska T; Kandefer-Szerszeń M; Szuster-Ciesielska A; Rzeszowska G; Markowska H; Modrzewska R
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):353-7. PubMed ID: 9017151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.